Skip to main content
The Journal of Headache and Pain logoLink to The Journal of Headache and Pain
. 2010 Oct 8;11(6):485–495. doi: 10.1007/s10194-010-0260-x

Neurogenic inflammation: a study of rat trigeminal ganglion

Kim Anker Kristiansen 1,, Lars Edvinsson 1
PMCID: PMC3476228  PMID: 20931347

Abstract

Calcitonin gene-related peptide (CGRP) is linked to neurogenic inflammation and to migraine. Activation of the trigeminovascular system plays a prominent role during migraine attacks with the release of CGRP. The trigeminal ganglion (TG) contains three main cell types: neurons, satellite glial cells (SGC) and Schwann cells; the first two have before been studied in vitro separately. Culture of rat TG provides a method to induce inflammation and the possibility to evaluate the different cell types in the TG simultaneously. We investigated expression levels of various inflammatory cytokines on mRNA level using RT-PCR arrays and qRT-PCR; furthermore expression at protein level was studied using immunohistochemistry. We report that (1) organ culture of the TG is possible with preserved morphology, (2) organ culture is associated with enhanced expression of cytokines and mitogen-activated protein kinases (MAPKs) primarily in neurons, (3) CGRP can induce expression of some cytokines and (4) cytokine expression is still upregulated following MAPK pathway inhibition by MEK inhibitor U0126 and pp38 inhibitor SB202192, but the cytokine expression is abolished when co-incubating with the JNK inhibitor SP600125. This method may be of value to examine local TG inflammation, putatively involved in the pathophysiology of some forms of primary headaches.

Keywords: Calcitonin gene-related peptide, Cytokines, Inflammation, Primary headache, Trigeminal ganglia

Full Text

The Full Text of this article is available as a PDF (609.3 KB).

Acknowledgments

This work was supported by the Lundbeck Foundation via the Lundbeck Foundation Center for Neurovascular Signalling (LUCENS).

Conflict of interest

None.

References

  • 1.Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28:183–187. doi: 10.1002/ana.410280213. [DOI] [PubMed] [Google Scholar]
  • 2.Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology. 2005;64:S9–S15. doi: 10.1212/wnl.64.10_suppl_2.s9. [DOI] [PubMed] [Google Scholar]
  • 3.Eftekhari S, Salvatore CA, Calamari A, Kane SA, Tajti J, Edvinsson L. Differential distribution of calcitonin gene-related peptide (CGRP) and CGRP receptor components (CLR and RAMP1) in the human trigeminal ganglion. Neuroscience. 2010;169:683–696. doi: 10.1016/j.neuroscience.2010.05.016. [DOI] [PubMed] [Google Scholar]
  • 4.Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, et al. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol. 2008;507:1277–1299. doi: 10.1002/cne.21607. [DOI] [PubMed] [Google Scholar]
  • 5.Thalakoti S, Patil VV, Damodaram S, Vause CV, Langford LE, Freeman SE, et al. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache. 2007;47:1008–1023. doi: 10.1111/j.1526-4610.2007.00854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kristiansen KA, Edvinsson L. Expressional change in calcitonin gene-related peptide, receptor activity modifying protein 1 (RAMP1) and bradykinin 1 receptor after experimen-tal inflammation in rat trigeminal ganglia. Curr Neurobiol. 2010;1:82–88. [Google Scholar]
  • 7.Bockowski L, Sobaniec W, Zelazowska-Rutkowska B. Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol. 2009;41:17–21. doi: 10.1016/j.pediatrneurol.2009.02.001. [DOI] [PubMed] [Google Scholar]
  • 8.Perini F, D’Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, et al. Plasma cytokine levels in migraineurs and controls. Headache. 2005;45:926–931. doi: 10.1111/j.1526-4610.2005.05135.x. [DOI] [PubMed] [Google Scholar]
  • 9.Fidan I, Yuksel S, Ymir T, Irkec C, Aksakal FN. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol. 2006;171:184–188. doi: 10.1016/j.jneuroim.2005.10.005. [DOI] [PubMed] [Google Scholar]
  • 10.Durham PL. Calcitonin gene-related peptide (CGRP) and migraine. Headache. 2006;46(Suppl 1):S3–S8. doi: 10.1111/j.1526-4610.2006.00483.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Reuter U, Bolay H, Jansen-Olesen I, Chiarugi A, Sanchez del RM, Letourneau R, et al. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain. 2001;124:2490–2502. doi: 10.1093/brain/124.12.2490. [DOI] [PubMed] [Google Scholar]
  • 12.Takeda M, Tanimoto T, Kadoi J, Nasu M, Takahashi M, Kitagawa J, et al. Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation. Pain. 2007;129:155–166. doi: 10.1016/j.pain.2006.10.007. [DOI] [PubMed] [Google Scholar]
  • 13.Allen NJ, Barres BA. Neuroscience: glia—more than just brain glue. Nature. 2009;457:675–677. doi: 10.1038/457675a. [DOI] [PubMed] [Google Scholar]
  • 14.Tajti J, Kuris A, Vecsei L, Xu C-B, Edvinsson L (2010) Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2. Cephalalgia. doi:10.1177/0333102410382796 [DOI] [PubMed]
  • 15.Park K-Y, Fletcher JR, Raddant AC, Russo AF (2010) Epigenetic regulation of the calcitonin/calcitonin gene-related peptide gene in trigeminal glia. Cephalalgia [DOI] [PMC free article] [PubMed]
  • 16.Hanani M. Satellite glial cells in sensory ganglia: from form to function. Brain Res Brain Res Rev. 2005;48:457–476. doi: 10.1016/j.brainresrev.2004.09.001. [DOI] [PubMed] [Google Scholar]
  • 17.Bowen EJ, Schmidt TW, Firm CS, Russo AF, Durham PL. Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons. J Neurochem. 2006;96:65–77. doi: 10.1111/j.1471-4159.2005.03524.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Vause CV, Durham PL. Calcitonin gene-related peptide differentially regulates gene and protein expression in trigeminal glia cells: findings from array analysis. Neurosci Lett. 2010;473:163–167. doi: 10.1016/j.neulet.2010.01.074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Capuano A, De CA, Lisi L, Tringali G, Navarra P, Dello RC. Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain. 2009;5:43. doi: 10.1186/1744-8069-5-43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Barbin G, Roisin MP, Zalc B. Tumor necrosis factor alpha activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary cultures of neurons. Neurochem Res. 2001;26:107–112. doi: 10.1023/A:1011086426652. [DOI] [PubMed] [Google Scholar]
  • 21.Durham PL, Russo AF. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci. 2003;23:807–815. doi: 10.1523/JNEUROSCI.23-03-00807.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bellamy J, Bowen EJ, Russo AF, Durham PL. Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci. 2006;23:2057–2066. doi: 10.1111/j.1460-9568.2006.04742.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Vause C, Bowen E, Spierings E, Durham P. Effect of carbon dioxide on calcitonin gene-related peptide secretion from trigeminal neurons. Headache. 2007;47:1385–1397. doi: 10.1111/j.1526-4610.2007.00850.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Vause CV, Durham PL. CGRP stimulation of iNOS and NO release from trigeminal ganglion glial cells involves mitogen-activated protein kinase pathways. J Neurochem. 2009;110:811–821. doi: 10.1111/j.1471-4159.2009.06154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ogawa T, Homma T, Igawa Y, Seki S, Ishizuka O, Imamura T, et al. CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis. J Urol. 2010;183:1206–1212. doi: 10.1016/j.juro.2009.11.007. [DOI] [PubMed] [Google Scholar]
  • 26.Silver RF, Walrath J, Lee H, Jacobson BA, Horton H, Bowman MR, et al. Human alveolar macrophage gene responses to Mycobacterium tuberculosis strains H37Ra and H37Rv. Am J Respir Cell Mol Biol. 2009;40:491–504. doi: 10.1165/rcmb.2008-0219OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Myskiw C, Arsenio J, van BR, Deschambault Y, Cao J. Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways. J Virol. 2009;83:6757–6768. doi: 10.1128/JVI.02570-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Boldt S, Kolch W. Targeting MAPK signalling: prometheus’ fire or pandora’s box? Curr Pharm Des. 2004;10:1885–1905. doi: 10.2174/1381612043384420. [DOI] [PubMed] [Google Scholar]
  • 29.Manthey CL, Wang SW, Kinney SD, Yao Z. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol. 1998;64:409–417. doi: 10.1002/jlb.64.3.409. [DOI] [PubMed] [Google Scholar]
  • 30.Edvinsson L. CGRP-receptor antagonism in migraine treatment. Lancet. 2008;372:2089–2090. doi: 10.1016/S0140-6736(08)61710-9. [DOI] [PubMed] [Google Scholar]
  • 31.Ansar S, Edvinsson L. Subtype activation and interaction of protein kinase C and mitogen-activated protein kinase controlling receptor expression in cerebral arteries and microvessels after subarachnoid hemorrhage. Stroke. 2008;39:185–190. doi: 10.1161/STROKEAHA.107.487827. [DOI] [PubMed] [Google Scholar]
  • 32.Horstmann S, Kahle PJ, Borasio GD. Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro. J Neurosci Res. 1998;52:483–490. doi: 10.1002/(SICI)1097-4547(19980515)52:4<483::AID-JNR12>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  • 33.Martin P, Poggi MC, Chambard JC, Boulukos KE, Pognonec P. Low dose cadmium poisoning results in sustained ERK phosphorylation and caspase activation. Biochem Biophys Res Commun. 2006;350:803–807. doi: 10.1016/j.bbrc.2006.09.126. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Headache and Pain are provided here courtesy of BMC

RESOURCES